Cargando…

Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study

Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocam...

Descripción completa

Detalles Bibliográficos
Autores principales: Noristani, H N, Meadows, R S, Olabarria, M, Verkhratsky, A, Rodríguez, J J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186898/
https://www.ncbi.nlm.nih.gov/pubmed/21918544
http://dx.doi.org/10.1038/cddis.2011.79
_version_ 1782213312998539264
author Noristani, H N
Meadows, R S
Olabarria, M
Verkhratsky, A
Rodríguez, J J
author_facet Noristani, H N
Meadows, R S
Olabarria, M
Verkhratsky, A
Rodríguez, J J
author_sort Noristani, H N
collection PubMed
description Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocampal CA1 in an AD triple transgenic mouse model (3xTg-AD). Here, we analyse the ultrastructural localisation, distribution and numerical density (N(v)) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-Te) and their relationship with SERT fibre sprouting and altered synaptic N(v) in 3xTg-AD compared with non-transgenic control mice. 3xTg-AD animals showed a significant increase in SERT-Te N(v) in CA1 at both, 3 (95%) and 18 months of age (144%), being restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced N(v) of perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the N(v) of symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te N(v) increase and PS reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efficacy as a response to the AD cognitive impairment.
format Online
Article
Text
id pubmed-3186898
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-31868982011-11-21 Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study Noristani, H N Meadows, R S Olabarria, M Verkhratsky, A Rodríguez, J J Cell Death Dis Original Article Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocampal CA1 in an AD triple transgenic mouse model (3xTg-AD). Here, we analyse the ultrastructural localisation, distribution and numerical density (N(v)) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-Te) and their relationship with SERT fibre sprouting and altered synaptic N(v) in 3xTg-AD compared with non-transgenic control mice. 3xTg-AD animals showed a significant increase in SERT-Te N(v) in CA1 at both, 3 (95%) and 18 months of age (144%), being restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced N(v) of perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the N(v) of symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te N(v) increase and PS reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efficacy as a response to the AD cognitive impairment. Nature Publishing Group 2011-09 2011-09-15 /pmc/articles/PMC3186898/ /pubmed/21918544 http://dx.doi.org/10.1038/cddis.2011.79 Text en Copyright © 2011 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Noristani, H N
Meadows, R S
Olabarria, M
Verkhratsky, A
Rodríguez, J J
Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title_full Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title_fullStr Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title_full_unstemmed Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title_short Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study
title_sort increased hippocampal ca1 density of serotonergic terminals in a triple transgenic mouse model of alzheimer's disease: an ultrastructural study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186898/
https://www.ncbi.nlm.nih.gov/pubmed/21918544
http://dx.doi.org/10.1038/cddis.2011.79
work_keys_str_mv AT noristanihn increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy
AT meadowsrs increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy
AT olabarriam increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy
AT verkhratskya increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy
AT rodriguezjj increasedhippocampalca1densityofserotonergicterminalsinatripletransgenicmousemodelofalzheimersdiseaseanultrastructuralstudy